US Patent Issued to Vasthera on March 17 for "Pharmaceutical composition comprising epidithiodioxopiperazine compound or derivative thereof, or pharmaceutically acceptable salt thereof, for preventing or treating pulmonary hypertension" (South Korean Inve

Media coverage

• Title	US Patent Issued to Vasthera on March 17 for "Pharmaceutical composition comprising epidithiodioxopiperazine compound or derivative thereof, or pharmaceutically acceptable salt thereof, for preventing or treating pulmonary hypertension" (South Korean Inve
  Media name/outlet	US Fed News
  Country/Territory	United States
  Date	18/03/20
  Persons	Sang Won Kang